Cardlytics, Inc.CDLXNASDAQ
LOADING
|||

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Mar 13, 2025Lake Street
Cardlytics price target lowered to $3 from $5 at Lake Street
Target:$3.00
+44.9%from $2.07
Oct 11, 2024Evercore ISI
Cardlytics initiated with an In Line at Evercore ISI
Target:$4.00
+24.2%from $3.22
Aug 16, 2024Northland Securities
Cardlytics downgraded to Market Perform from Outperform at Northland
Target:$5.00
+33.3%from $3.75
Aug 15, 2024Bank of America Securities
Cardlytics downgraded to Underperform from Neutral at BofA
Target:$3.50
-5.1%from $3.69
Aug 8, 2024Craig-Hallum
Craig-Hallum downgrades Cardlytics to Hold following CEO news, Q3 guide
Target:$4.00
+35.1%from $2.96
Aug 8, 2024Northland Securities
Cardlytics price target lowered to $7 from $14 at Northland
Target:$7.00
+1.4%from $6.90
Jun 18, 2024Northland Securities
Northland Starts Cardlytics (CDLX) at Outperform
Target:$14.00
+70.6%from $8.21
Apr 9, 2024Needham
Cardlytics (CDLX) PT Raised to $17 at Needham
Target:$17.00
+21.3%from $14.01
Aug 2, 2023Needham
Cardlytics' Relationships With Top US Banks Is Key To Targeted Marketing Success: Analyst
Target:$19.00
+41.0%from $13.48
Nov 2, 2022Needham
Cardlytics Sees Price Target Cut By 26% To Reflect Macro Headwinds
Target:$14.00
+145.6%from $5.70
May 3, 2022Craig-Hallum
Cardlytics price target lowered to $50 from $70 at Craig-Hallum
Target:$50.00
+39.4%from $35.86
May 3, 2022Needham
Needham Maintains Buy on Cardlytics, Lowers Price Target to $60
Target:$60.00
+67.3%from $35.86